Find clinical trials for psoriatic arthritis. Search for psoriatic arthritis clinical trials in different cities and states across the United States.
Sponsor:
Fiechtner, Justus J., M.D., P.C.
Location:
Code:
NCT01939132
Conditions
Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Open label H.P. Acthar Gel
Sponsor:
Brigham and Women's Hospital
Location:
Code:
NCT06004700
Conditions
Arthritis
Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Mobile Application
Sponsor:
Ortho Development Corporation
Location:
Code:
NCT03986918
Conditions
Joint Diseases
Osteoarthritis, Hip
Rheumatoid Arthritis
Psoriatic Arthritis
Avascular Necrosis of Hip
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Routine Total Hip Arthroplasty
Get alerts for new trials in your area by subscribing now
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06751238
Conditions
Juvenile Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 2 - 17
Healthy Volunteers: Not accepted
Interventions
Secukinumab
Sponsor:
McMaster University
Location:
Code:
NCT05545839
Conditions
Juvenile Idiopathic Arthritis
Juvenile Rheumatoid Arthritis
Juvenile Dermatomyositis
Juvenile Psoriatic Arthritis
Autoinflammatory Disease
Eligibility Criteria
Sex: All
Age: 17 - 18
Healthy Volunteers: Not accepted
Interventions
Transition coaching
Sponsor:
University of Pennsylvania
Location:
Code:
NCT05631223
Conditions
Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Telemedicine
Sponsor:
Sun Pharmaceutical Industries Limited
Location:
Code:
NCT04991116
Conditions
Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TILD sub-cutaneous (SC) injection
Sponsor:
UCB Biopharma SRL
Location:
Code:
NCT06506916
Conditions
Moderate to Severe Plaque Psoriasis
Psoriatic Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Accepted
Interventions
bimekizumab